MENU

发表文章

Preclinical development of a bispecific antibody-trap selectively targeting CD47 and CD20 for the treatment of B cell lineage cancer. Tian et al, AACR, 2019.

发布日期:2020-07-08 浏览次数:26

POSTER: Preclinical development of a bispecific antibody-trap selectively targeting CD47 and CD20 for the treatment of B cell lineage cancer. Tian et al, AACR, 2019.